Diabetes treatments increase risk of heart problems in older patients, study finds
Older diabetes patients treated with Takeda Pharmaceutical North American Inc.'s Actos and GlaxoSmithKline Plc.'s Avandia had a "significant" increased risk of heart attack, congestive heart failure and death compared to those taking an older treatment for people with diabetes, according to a study in this week's Journal of the American ...
